NCT04272281 (ARIBO) is a NA clinical trial of medical shared decision in Cystitis, sponsored by University Hospital, Bordeaux.

Who is sponsoring NCT04272281?

NCT04272281 is sponsored by University Hospital, Bordeaux.

What drugs are being tested in NCT04272281?

Interventions in NCT04272281: medical shared decision, Standard medical care.

Is NCT04272281 still recruiting?

NCT04272281 is currently completed. Last updated 9 March 2022.

Last reviewed 2022-03-09 · How we verify

NCT04272281: ARIBO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of a Share Decision Making Tool in the Care of Acute Cystitis Without Risk of Complication in Primary Care

Completed NA Last updated 9 March 2022

What this trial tests

NA trial testing medical shared decision in Cystitis in 169 participants. Completed in 17 February 2022.

Timeline

22 July 2020

Primary endpoint
3 December 2021

17 February 2022

Quick facts

Lead sponsor	University Hospital, Bordeaux
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	169
Start date	22 July 2020
Primary completion	3 December 2021
Estimated completion	17 February 2022
Sites	1 location across France

Drugs / interventions tested

medical shared decision
Standard medical care — full drug profile →

Conditions studied

Cystitis — all drugs for Cystitis →

Sponsor

University Hospital, Bordeaux

Who can join

Adults 18 to 65, female only, with Cystitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the aim of this trial is to demonstrate that when caring women with symptoms of acute cystitis without any risk of complication, general practitioner may use share decision making tool to help patients better understand the stakes of taking antibiotics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04272281 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 9 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04272281.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing